Taysha Gene Therapies (TSHA) Short Interest Ratio & Short Volume → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free TSHA Stock Alerts $3.17 +0.11 (+3.59%) (As of 03/27/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Taysha Gene Therapies Short Interest DataCurrent Short Volume15,810,000 sharesPrevious Short Volume13,880,000 sharesChange Vs. Previous Month+13.90%Dollar Volume Sold Short$36.36 millionShort Interest Ratio / Days to Cover6.0Last Record DateMarch 15, 2024Outstanding Shares187,020,000 sharesPercentage of Shares Shorted8.45%Today's Trading Volume2,502,699 sharesAverage Trading Volume4,469,505 sharesToday's Volume Vs. Average56% Short Selling Taysha Gene Therapies ? Sign up to receive the latest short interest report for Taysha Gene Therapies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTSHA Short Interest Over TimeTSHA Days to Cover Over TimeTSHA Percentage of Float Shorted Over Time Ad Prosper Trading AcademyThis AI Trade Machine Made 1,729%* (With 89% Wins)What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy Taysha Gene Therapies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202415,810,000 shares $36.36 million +13.9%N/A6 $2.30 2/29/202413,880,000 shares $43.86 million -14.9%N/A6.3 $3.16 2/15/202416,300,000 shares $25.92 million -2.9%N/A8.3 $1.59 1/31/202416,780,000 shares $25.51 million -4.1%N/A8 $1.52 1/15/202417,490,000 shares $27.98 million -0.2%N/A7.8 $1.60 12/31/202317,530,000 shares $31.03 million +2.3%N/A7.8 $1.77 Get the Latest News and Ratings for TSHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Taysha Gene Therapies and its competitors with MarketBeat's FREE daily newsletter. 12/15/202317,130,000 shares $27.92 million +6.0%N/A8.2 $1.63 11/30/202316,160,000 shares $28.44 million +15.8%N/A7.6 $1.76 11/15/202313,950,000 shares $23.44 million +42.9%N/A5.6 $1.68 10/31/20239,760,000 shares $22.84 million -2.6%N/A1.8 $2.34 10/15/202310,020,000 shares $22.65 million -6.1%N/A1.9 $2.26 9/30/202310,670,000 shares $33.72 million +7.5%N/A2.1 $3.16 9/15/20239,930,000 shares $32.67 million +34.9%N/A2.1 $3.29 8/31/20237,360,000 shares $23.55 million +902.0%N/A1.6 $3.20 8/15/2023734,500 shares $1.60 million -33.2%3.9%0.2 $2.18 7/31/20231,100,000 shares $740,520.00 -1.8%3.0%4.4 $0.67 7/15/20231,120,000 shares $773,920.00 -12.5%3.1%4.3 $0.69 6/30/20231,280,000 shares $846,080.00 -10.5%3.5%4 $0.66 6/15/20231,430,000 shares $1.09 million +16.3%3.8%3.7 $0.77 5/31/20231,230,000 shares $859,647.00 +3.4%3.4%3.2 $0.70 5/15/20231,190,000 shares $824,789.00 -31.2%3.2%3 $0.69 4/30/20231,730,000 shares $1.34 million +6.1%4.7%4.1 $0.78 4/15/20231,630,000 shares $1.42 million -15.5%4.5%2.9 $0.87 3/31/20231,930,000 shares $1.54 million -18.2%5.4%3.5 $0.80 3/15/20232,360,000 shares $2.07 million -11.6%6.5%4.4 $0.88 2/28/20232,670,000 shares $2.70 million +19.7%7.3%4.7 $1.01 2/15/20232,230,000 shares $2.41 million +2.3%6.1%3.7 $1.08 1/31/20232,180,000 shares $3.58 million +26.7%6.0%2.7 $1.64 1/15/20231,720,000 shares $3.96 million +25.6%4.7%0.7 $2.30 12/30/20221,370,000 shares $3.10 million +48.0%3.8%0.5 $2.26 12/15/2022925,700 shares $2.13 million +12.3%2.5%0.4 $2.30 11/30/2022824,500 shares $1.82 million -38.5%3.8%0.3 $2.21 11/15/20221,340,000 shares $2.95 million -19.8%6.3%0.6 $2.20 10/31/20221,670,000 shares $2.87 million +73.8%11.3%0.8 $1.72 10/15/2022960,700 shares $1.53 million +8.0%4.1%0.6 $1.59 9/30/2022889,600 shares $1.72 million -5.2%3.8%8.5 $1.93 9/15/2022938,700 shares $2.92 million +5.2%4.0%6.2 $3.11 8/31/2022892,600 shares $2.82 million +3.5%3.8%5.3 $3.16 8/15/2022862,300 shares $3.74 million -7.2%3.7%4 $4.34 7/31/2022929,100 shares $3.78 million -10.7%4.1%3.8 $4.07Top Project Outperforms BTC in 2023… (Ad)According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024. TSHA Short Interest - Frequently Asked Questions What is Taysha Gene Therapies' current short interest? Short interest is the volume of Taysha Gene Therapies shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 15,810,000 shares of TSHA short. Learn More on Taysha Gene Therapies' current short interest. What is a good short interest ratio for Taysha Gene Therapies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TSHA shares currently have a short interest ratio of 6.0. Learn More on Taysha Gene Therapies's short interest ratio. Which institutional investors are shorting Taysha Gene Therapies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Taysha Gene Therapies: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Taysha Gene Therapies' short interest increasing or decreasing? Taysha Gene Therapies saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 15,810,000 shares, an increase of 13.9% from the previous total of 13,880,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Taysha Gene Therapies' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Taysha Gene Therapies: Alector, Inc. (8.04%), Valneva SE (0.06%), Editas Medicine, Inc. (17.03%), C4 Therapeutics, Inc. (7.71%), Solid Biosciences Inc. (2.04%), Novavax, Inc. (34.39%), Tourmaline Bio, Inc. (4.29%), Replimune Group, Inc. (15.46%), Ocugen, Inc. (13.80%), Caribou Biosciences, Inc. (12.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Taysha Gene Therapies stock? Short selling TSHA is an investing strategy that aims to generate trading profit from Taysha Gene Therapies as its price is falling. TSHA shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Taysha Gene Therapies? A short squeeze for Taysha Gene Therapies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TSHA, which in turn drives the price of the stock up even further. How often is Taysha Gene Therapies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TSHA, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ALEC Short Squeeze VALN Short Squeeze EDIT Short Squeeze CCCC Short Squeeze SLDB Short Squeeze NVAX Short Squeeze TRML Short Squeeze REPL Short Squeeze OCGN Short Squeeze CRBU Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TSHA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits